超选择性肝动脉栓塞化疗治疗老年原发性肝癌的疗效观察  

Curative effect of super selective hepatic artery embolism chemotherapy on senile patients with primary liver cancer

作　　者：张世杰[1] 吕云福[2] 方万强[1] 付春利[1] 邓国敏[1] 

机构地区：[1]开平市中心医院肿瘤外科,广东江门529300 [2]海南省人民医院普通外科,海南海口570311

出　　处：《中国热带医学》2013年第4期487-489,共3页China Tropical Medicine

摘　　要：目的研究超选择性肝动脉栓塞化疗(STACE)治疗老年肝癌的临床疗效。方法应用超选择性肝动脉栓塞化疗技术对35例老年原发性肝癌行肝动脉化疗栓塞术。结果 35例使用STACE治疗76次,平均治疗2.2次,全部操作成功。术后恢复迅速,无严重并发症,平均住院6.6d。治疗后2个月复查肿瘤CT及AFP,缩小大于50%者14例次(40%),肿瘤缩小于50%但大于25%者17例次(49%),肿瘤无明显变化进展4例(11%)。生存期均大于6月。结论 STACE具有简单、方便、疗效好,副反应轻,对老年肝癌不愿手术或不能耐受手术的治疗中具有重要的临床应用价值。Objective To observe the curative effect of super selective hepatic artery embolism chemotherapy（STACE）on senile liver cancer patients.Methods Super selective hepatic artery embolism chemotherapy technology was applied for treatment of 35 senile primary liver cancer.Results the 35 cases were treated with STACE treatment for 76 times and averagely 2.2 times per patient.The treatment was successful and the patients revered soon without severe adverse reactions and with an average hospitalization of 6.6 days.The results of checkup by using tumor CT and AFF two months after the treatment showed that the tumor size shrank by 50% in 14 cases accounted for（40%）and the tumor sized shrank shrank by 25%-50% accounted for 49%）,and no changed were observed in 4 cases accounted for 11%.The survival rate was over 6 months.Conclusions STACE is a simple,convenient and effective method for treatment of senile liver cancer patients intolerable or reluctant to surgery treatment.

关 键 词：超选择性 栓塞化疗 老年 肝癌. 

分 类 号：R512.62[医药卫生—内科学]